These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19287455)

  • 21. MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells.
    Wang Y; Wang M; Abarbanell AM; Weil BR; Herrmann JL; Tan J; Novotny NM; Coffey AC; Meldrum DR
    Surgery; 2009 Aug; 146(2):198-205. PubMed ID: 19628074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A TRAF2 binding independent region of TNFR2 is responsible for TRAF2 depletion and enhancement of cytotoxicity driven by TNFR1.
    Cabal-Hierro L; Artime N; Iglesias J; Prado MA; Ugarte-Gil L; Casado P; Fernández-García B; Darnay BG; Lazo PS
    Oncotarget; 2014 Jan; 5(1):224-36. PubMed ID: 24318359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peg3/Pw1 is an imprinted gene involved in the TNF-NFkappaB signal transduction pathway.
    Relaix F; Wei XJ; Wu X; Sassoon DA
    Nat Genet; 1998 Mar; 18(3):287-91. PubMed ID: 9500555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action.
    Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K
    J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia.
    Columbano A; Ledda-Columbano GM; Pibiri M; Cossu C; Menegazzi M; Moore DD; Huang W; Tian J; Locker J
    Hepatology; 2005 Nov; 42(5):1118-26. PubMed ID: 16231353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.
    Arnott CH; Scott KA; Moore RJ; Robinson SC; Thompson RG; Balkwill FR
    Oncogene; 2004 Mar; 23(10):1902-10. PubMed ID: 14661063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis.
    Onizawa M; Nagaishi T; Kanai T; Nagano K; Oshima S; Nemoto Y; Yoshioka A; Totsuka T; Okamoto R; Nakamura T; Sakamoto N; Tsuchiya K; Aoki K; Ohya K; Yagita H; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G850-9. PubMed ID: 19179628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
    Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
    Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells.
    Twu YC; Gold MR; Teh HS
    Eur J Immunol; 2011 Feb; 41(2):335-44. PubMed ID: 21268004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling.
    Siegmund D; Ehrenschwender M; Wajant H
    Cell Death Dis; 2018 Sep; 9(9):921. PubMed ID: 30206205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production.
    Markel TA; Crisostomo PR; Wang M; Herring CM; Meldrum DR
    Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G657-62. PubMed ID: 17640973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B7.2 on activated and phagocytic microglia in the facial axotomy model: regulation by interleukin-1 receptor type 1, tumor necrosis factor receptors 1 and 2 and endotoxin.
    Bohatschek M; Kloss CU; Pfeffer K; Bluethmann H; Raivich G
    J Neuroimmunol; 2004 Nov; 156(1-2):132-45. PubMed ID: 15465604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2).
    Rauert H; Wicovsky A; Müller N; Siegmund D; Spindler V; Waschke J; Kneitz C; Wajant H
    J Biol Chem; 2010 Mar; 285(10):7394-404. PubMed ID: 20038584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brefeldin A-Inhibited Guanine Nucleotide-Exchange Factor 1 (BIG1) Governs the Recruitment of Tumor Necrosis Factor Receptor-Associated Factor 2 (TRAF2) to Tumor Necrosis Factor Receptor 1 (TNFR1) Signaling Complexes.
    Noguchi T; Tsuchida M; Kogue Y; Spadini C; Hirata Y; Matsuzawa A
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct differences between TNF receptor 1- and TNF receptor 2-mediated activation of NFkappaB.
    Thommesen L; Laegreid A
    J Biochem Mol Biol; 2005 May; 38(3):281-9. PubMed ID: 15943902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of NFkappaB signal pathways in keloid fibroblasts.
    Messadi DV; Doung HS; Zhang Q; Kelly AP; Tuan TL; Reichenberger E; Le AD
    Arch Dermatol Res; 2004 Aug; 296(3):125-33. PubMed ID: 15278366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-kappaB signal triggering and termination by tumor necrosis factor receptor 2.
    Rodríguez M; Cabal-Hierro L; Carcedo MT; Iglesias JM; Artime N; Darnay BG; Lazo PS
    J Biol Chem; 2011 Jul; 286(26):22814-24. PubMed ID: 21558270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1.
    Kieser A
    Biol Chem; 2008 Oct; 389(10):1261-71. PubMed ID: 18713013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creation of an improved mutant TNF with TNFR1-selectivity and antagonistic activity by phage display technology.
    Nomura T; Abe Y; Kamada H; Inoue M; Kawara T; Arita S; Furuya T; Minowa K; Yoshioka Y; Shibata H; Kayamuro H; Yamashita T; Nagano K; Yoshikawa T; Mukai Y; Nakagawa S; Tsunoda S; Tsutsumi Y
    Pharmazie; 2010 Feb; 65(2):93-6. PubMed ID: 20225650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis.
    Zhao X; Mohaupt M; Jiang J; Liu S; Li B; Qin Z
    Cancer Res; 2007 May; 67(9):4443-50. PubMed ID: 17483359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.